Last Updated: May 20, 2026

Claims for Patent: 10,927,164

✉ Email this page to a colleague

Summary for Patent: 10,927,164

Title:	Method for protein purification
Abstract:	The present invention provides a method for recovering a human VH3 domain-containing antibody in monomeric form. In particular the present invention provides a new method that allows recovery of monomeric human VH3 domain-containing antibodies from a mixture containing monomeric and multimeric forms of the antibody.
Inventor(s):	Sam Philip Heywood, Gavin Barry Wild
Assignee:	UCB Biopharma SRL
Application Number:	US15/566,231

Details for Patent 10,927,164

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kite Pharma Inc.	TECARTUS	brexucabtagene autoleucel	For Injection	125703	July 24, 2020	10,927,164	2036-04-20
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,927,164

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016169992	⤷ Start Trial
United States of America	2021171609	⤷ Start Trial
United States of America	2018100007	⤷ Start Trial
Singapore	11201708256Y	⤷ Start Trial
Malaysia	189854	⤷ Start Trial
Mexico	392543	⤷ Start Trial
Mexico	2017013333	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.